OMT protected against cirrhosis-associated intestinal mucosal damage via inhibiting NF-κB-mediated signalling and attenuated intestinal ischaemia/reperfusion injury in rats via inhibiting TNF-α and p-p38/MAPK signalling (Wen et al. This evidence concerns the gene TNF and Cirrhosis.